Human IgE-independent systemic anaphylaxis

• Published in: Journal of allergy and clinical immunology Vol. 137; no. 6; pp. 1674 - 1680
• Main Authors: Finkelman, Fred D., Khodoun, Marat V., Strait, Richard
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2016; Elsevier Limited
• Subjects: Allergies; Allergy and Immunology; Anaphylatoxin; Anaphylaxis - immunology; Anaphylaxis - metabolism; Animals; Antigens; basophil; Basophils - immunology; Basophils - metabolism; complement; Complement System Proteins - immunology; Complement System Proteins - metabolism; Cytokines; Disease Models, Animal; Drug Hypersensitivity - immunology; Drug Hypersensitivity - metabolism; FcγR; FcεR; Human subjects; Humans; IgE; IgG; Immunization; Immunoglobulin E - immunology; Immunoglobulin G - immunology; Immunoglobulins; mast cell; Mast Cells - immunology; Mast Cells - metabolism; Mice; mouse; Neutrophils; Proteins; Receptors, IgE - metabolism; Rodents; mouse; PAF; IgE; NSAID; TNP; IgG; mast cell; FcεR; basophil; Anaphylatoxin; complement; FcγR; Platelet-activating factor; Nonsteroidal anti-inflammatory drug; Trinitrophenyl
• ISSN: 0091-6749; 1097-6825; 1097-6825
• DOI: 10.1016/j.jaci.2016.02.015

Anaphylaxis is a rapidly developing, life-threatening, generalized or systemic allergic reaction that is classically elicited by antigen crosslinking of antigen-specific IgE bound to the high-affinity IgE receptor FcεRI on mast cells and basophils. This initiates signals that induce cellular degranulation with release and secretion of vasoactive mediators, enzymes, and cytokines. However, IgE-independent mechanisms of anaphylaxis have been clearly demonstrated in experimental animals. These include IgG-dependent anaphylaxis, which involves the triggering of mediator release by IgG/antigen complex crosslinking of FcγRs on macrophages, basophils, and neutrophils; anaphylaxis mediated by binding of the complement-derived peptides C3a and C5a to their receptors on mast cells, basophils, and other myeloid cells; and direct activation of mast cells by drugs that interact with receptors on these cells. Here we review the mechanisms involved in these IgE-independent forms of anaphylaxis and the clinical evidence for their human relevance. We conclude that this evidence supports the existence of all 3 IgE-independent mechanisms as important causes of human disease, although practical and ethical considerations preclude their demonstration to the degree of certainty possible with animal models. Furthermore, we cite evidence that different clinical situations can suggest different mechanisms as having a primal role in anaphylaxis and that IgE-dependent and distinct IgE-independent mechanisms can act together to increase anaphylaxis severity. As specific agents become available that can interfere with mechanisms involved in the different types of anaphylaxis, recognition of specific types of anaphylaxis is likely to become important for optimal prophylaxis and therapy.